News

Dr. Jim Castellanos, an instructor in anesthesiology, has been selected as a 2024 Hanna H. Gray Fellow by the Howard Hughes Medical Institute.

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery.

The five-year, $2.3 million grant from the Centers for Disease Control and Prevention will seek to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.

Awards, honors and achievements for the month of December.

The hormone estrogen regulates binge drinking in females, causing them to “pregame”—consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine. 

Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer’s disease by latching on to them, forming a sort of external stomach and releasing digestive enzymes into the space, according to a preclinical study by Weill Cornell Medicine investigators.

After years of research, Dr. Gary Gibson’s work has culminated in a nationwide clinical trial evaluating an entirely new treatment approach for slowing Alzheimer’s progression.

Accelerating BioVenture Innovation program Dec. 5 graduated another cohort with its signature pitch finale in Uris Auditorium and a networking reception.

A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.

Reinforcement Learning, an artificial intelligence approach, has the potential to guide physicians in designing sequential treatment strategies for better patient outcomes but requires significant improvements before it can be applied in clinical settings, finds a new study by Weill Cornell Medicine researchers.

Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.

A new study by Weill Cornell Medicine investigators has found that free fatty acids, including an omega-3 fatty acid called DHA, can reduce the amount of glutamate uptake by diminishing the sodium ion gradient that powers the transporters.

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.

Weill Cornell Medicine recently hosted the New York Pathological Society's Fall Mini-Symposium. 

Weill Cornell Medicine and Champions Oncology signed a licensing agreement allowing Champions Oncology to distribute and commercialize Weill Cornell Medicine’s extensive bank of hematological PDX models

Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.

Though using large language models (LLM) that drive artificial intelligence (AI) to draft patient notes shows promise in saving physicians time, they will still need to review and edit these summaries for accuracy, finds a new study by researchers at Weill Cornell Medicine. 

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.

Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease, according to Weill Cornell Medicine researchers.

Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Korea’s Yonsei University.